US-Japan collaboration for liquid biopsy screening in lung cancer
Singapore, Aug. 21 -- US-based Pillar Biosciences, Inc., LC-SCRUM-Asia and LSI Medience Corporation have announced a collaboration to support genomic screening of blood-based samples from patients with lung cancer as part of the LC-SCRUM-Asia project in Japan.
Published by HT Digital Content Services with permission from BioSpectrum Asia....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.